ebook Munafa Stock Market Course + Intraday & FNO calls  

       

524816 announcements Natco Pharm announcements and dividends declared BSE

Natco Pharm Complete list of announcements declared & dividend announcements by Natco Pharm 524816

Natco Pharm 524816 listed on BSE and deals in

Announcements and dividends declared by Natco Pharm 524816

Delhi HC asks Natco Pharma to pause Risdiplam launch amid patent dispute
The Delhi High Court has ordered Natco Pharma to maintain status quo on the launch of Risdiplam until April 2. Roche, which holds the patent for the drug, sought an injunction to prevent Natco from manufacturing it in India. The court highlighted the publi
Announcement as on 26 March 2025

Delhi HC rejects Roche's plea to block Natco Pharma on Risdiplam patent
The Delhi High Court denied Roche's request to temporarily restrain Natco Pharma from producing its spinal muscular atrophy drug, citing public interest and high prices. Natco is required to maintain detailed financial records and may owe damages if Roche
Announcement as on 24 March 2025

Breakdown Stocks: How to trade ITC, Natco Pharma and Birlasoft on Friday?
Indian markets declined for the third straight session, with Sensex dropping over 200 points while Nifty50 held 22,900. Oil & gas stocks gained, but FMCG and banks saw selling pressure. ITC, Natco Pharma, and Birlasoft hit fresh 52-week lows.
Announcement as on 20 February 2025

Concord Biotech, Natco Pharma among 10 smallcap stocks that crashed up to 41% this week
Here’s a look at the top 10 worst-performing stocks from the BSE Smallcap index during the week
Announcement as on 15 February 2025

NATCO Pharma Q3 Results: Profit declines 37% to Rs 132 crore
NATCO Pharma Ltd on Wednesday reported a 37.75 per cent decline in consolidated net profit to Rs 132.4 crore in the December quarter, hit by a drop in formulations exports.
Announcement as on 12 February 2025

Announcements by Natco Pharm first page | Next page | Prev page |

524816 Natco Pharm current price & indicator signals

Moving Averages for Natco Pharm

  • 5Day Average: 914.21
  • 12Day Average: 914.88
  • 20Day Average: 914.56
  • 50Day Average: 865.49
  • 100Day Average: 863.8
  • 150Day Average: 886
  • 200Day Average: 870

524816 Indicators & signals

Indicator MACD (12,26,9)

910.62, 898.48, 16.24
Indicator MACD is in positive zone

Indicator ADX (14)

14.38, 26.73, 20.01
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 55
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 524816 Natco Pharm are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
29 Mon Dec 2025 895.90 894.20 to 911.30 -1.34% 0.44 times
26 Fri Dec 2025 908.10 905.70 to 920.00 -0.89% 0.72 times
24 Wed Dec 2025 916.25 911.50 to 926.70 -1.18% 0.91 times
23 Tue Dec 2025 927.15 922.50 to 950.40 0.38% 0.55 times
22 Mon Dec 2025 923.65 910.90 to 927.00 0.63% 0.95 times
19 Fri Dec 2025 917.90 913.10 to 943.00 0.33% 1.14 times
18 Thu Dec 2025 914.85 910.95 to 924.35 -0.83% 0.87 times
17 Wed Dec 2025 922.50 913.05 to 929.40 0.05% 1 times
16 Tue Dec 2025 922.05 904.45 to 928.00 1.87% 1.1 times
15 Mon Dec 2025 905.10 895.55 to 918.00 -0.11% 1.03 times
12 Fri Dec 2025 906.10 900.95 to 923.85 -1.4% 1.73 times
11 Thu Dec 2025 918.95 866.70 to 933.25 5.93% 5.61 times

Videos related to: 524816 announcements Natco Pharm announcements and dividends declared BSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

524816 announcements Natco Pharm announcements and dividends declared BSE

 

Back to top